Growth, amino acid transport, and oxygen consumption of Escherichia coli and Salmonella typhimurium are inhibited by short-chain (C,-C.) but not by medium or long-chain fatty acids (C1O-C15) at concentrations at which these processes are completely inhibited in Bacillus subtilis. The resistance of gram-negative organisms is not correlated with their ability to metabolize fatty acids, since an E. coli mutant unable to transport oleic acid is still resistant. However, mutants of both E. coli and S. typhimurium in which the lipopolysaccharide layer does not contain the residues beyond the 2-keto-3-deoxyoctonate core are inhibited by medium (C 0) but not by long-chain (C,,) fatty acids.
Furthermore, removal of a portion of the lipopolysaccharide layer by ethylenediaminetetraacetate treatment renders the organisms sensitive to medium and partially sensitive to long-chain fatty acids. The intact lipopolysaccharide layer of gram-negative organisms apparently screens the cells against medium and long-chain fatty acids and prevents their accumulation on the inner cell membrane (site of amino acid transport) at inhibitory concentrations. These results are relevant to the use of antimicrobial food additives, and they allow the characterization of gram-positive versus gram-negative bacteria and their lipopolysaccharide mutants.
We have shown recently that fatty acids inhibit the growth and oxygen consumption of Bacillus subtilis in nutrient medium by inhibiting the transport of amino acids, keto acids, etc., through the cellular membrane (5) . The effectiveness of inhibition increased with increasing fatty acid chain length. In contrast, the inhibitory effect on Escherichia coli increased only up to a fatty acid chain length of six, hexanoate being as effective as on B. subtilis; decanoate inhibited only at a 50-times higher concentration, while long-chain fatty acids had no effect. Two explanations for this discrepancy were considered.
(i) Since E. coli can utilize long-chain fatty acids as carbon source, it can convert them to the acyl-coenzyme A (CoA) derivative and then metabolize them by ,8-oxidation (7) . B. subtilis cannot utilize them as carbon source and can metabolize only acetate at a high optimal concentration of 50 mM (3, 4) . Conceivably, E. coli might be able to metabolize rapidly any long-chain fatty acids that attach to the membrane so that they would be effectively removed from the membrane before they could exert any significant inhibitory effect. If that were true, mutants unable to take up or metabolize longchain fatty acids (7) should be inhibited by them.
(ii) Gram-negative bacteria are typically surrounded by a lipopolysaccharide (LPS) layer (10) which prevents the entry of compounds such as actinomycin D (6) and the action of lysozyme (11) . This LPS layer can be partially removed by exposure to ethylenediaminetetraacetate (EDTA), and organisms then become sensitive to actinomycin, lysozyme, and other compounds (8) . There are also mutants of E. coli (2) and S. typhimurium (1) in which the polysaccharide portion is partially or completely absent. Such mutants are much more sensitive than normal strains to carcinogens with high molecular weight (1) . If the LPS layer should also prevent the entry of long-chain fatty acids, its partial opening in mutants or by EDTA treatment might make the cells more accessible to fatty acid inhibition. Figure 1 shows the inhibition of growth and oxygen consumption. Whereas both organisms were equally sensitive to short-chain fatty acids up to hexanoate, E. coli was increasingly less sensitive than B. subtilis with increasing chain length. About twice as much octanoate was needed to inhibit E. coli to the same extent as B. subtilis, while for decanoate the amount needed was already 50 times higher. For oleate, no inhibition was observed up to 5 mM concentration. At these high concentrations, the longchain fatty acids remained mostly insoluble. Their solubility could be increased by the addition of 0.4% Triton X-100, which does not inhibit the growth of E. coli. However, the better-solubilized long-chain fatty acids still did not cause any significant growth inhibition. Triton X-100 lyses B. subtilis even when it is by the beta-oxidation enzymes. The other mutant (50009) was derived from this strain but lacks the acyl-CoA synthetase activity and is, therefore, unable to take up or metabolize long-chain fatty acids (7). Figure 2 shows that both strains were equally inhibited by hexanoate (20 mM), whereas they were both not inhibited by decanoate (2 mM) or oleate (1 mM)) at concentrations which completely inhibit the growth of B. subtilis. The inhibition of oxygen consumption by decanoate also showed the same concentration dependence for both mutants as well as for the earlier used strains of E. coli (50019) in which the metabolism of long-chain fatty acids is inducible (Fig. 1) . We used at concentrations as low as 0.05%, which is not sufficient to significantly solubilize longchain fatty acids. The protection of gram-negative bacteria gainst Triton X-100 presumably is due to the presence of the LPS layer and is likely to be reduced or to disappear when mutants or treatments are used that open up this layer. For this reason, Triton X-100 was not used further except when specifically mentioned.
The uptake of L-glycine was similarly inhibited by all fatty acids in B. subtilis, whereas only the short-chain fatty acids were effective in E. coli ( (Table 3 ). The same observation was made for two S. typhimurium strains, one of which (50016) has the normal LPS, whereas the other (50015) has a deletion which eliminates the whole galactose operon and, in addition, lacks some enzyme needed for the elongation of the polysaccharide beyond the KDO core (1) . Again, growth of the normal strain was not inhibited by 2 mM decanoate, while that of the LPS mutant was completely inhibited (Table 3) . Since the latter strain (50015) requires histidine for growth, several histidine-independent revertants were isolated from it as control; their growth was also inhibited by 2 (Table 3 ). The growth of both KDO mutants was inhibited in NBP liquid containing 0.4% Triton X-100, while the growth of normal E. coli and S. typhimurium was unaffected ( Table 3) .
The effect of different decanoate concentrations on oxygen consumption and glycine uptake by the above strains is shown in Fig. 3 Figure 4 shows the growth response of treated and untreated cells to decanoate and linoleate or oleate. The cells were clearly sensitized by the EDTA treatment so that they showed either a growth inhibition or cell lysis. At some later time, depending on the fatty acid concentration, growth resumed, apparently because some of the cells had reformed their LPS layer and thus had become resistant again. While this result agreed with the above mutant observations, concentrations of linoleate or oleate exceeding 0.5 mM were increasingly less effective inhibited with increasing effectiveness, and even oleate showed up to 50% inhibition (Fig.  5) . EDTA treatment also sensitized the oxygen consumption of E. coli to the long-chain fatty acids ( (9) . Following this treatment, the uptake of amino acids and the consumption of oxygen are inhibited even by the long-chain fatty acids. Growth is also transiently inhibited (or some cells are lysed) until a sufficient number of cells have reformed their LPS layer to become again resistant; then growth resumes. The holes produced in the LPS layer by EDTA treatment apparently are slightly larger than those present in LPS mutants that are stripped down to the KDO core, because the mutants do not become sensitive to long-chain fatty acids. EDTA is sometimes used as a food additive in addition to lipophilic acids, possibly because it enhances the inhibitory effect of the lipophilic acids on gram-negative organisms; whether consumption of EDTA is harmless to humans will depend on the amount of metals present in the gut.
